NO20043698L - Combination preparation of the sodium hydrogen exchange inhibitor cariporide with ACE inhibitors for heart failure prevention and other age-related dysfunctions in organs, age-related diseases and for extended life - Google Patents

Combination preparation of the sodium hydrogen exchange inhibitor cariporide with ACE inhibitors for heart failure prevention and other age-related dysfunctions in organs, age-related diseases and for extended life

Info

Publication number: NO20043698L
Authority: NO; Norway
Prior art keywords: age; organs; heart failure; sodium hydrogen; ace inhibitors
Prior art date: 2002-02-04

Application number

NO20043698A

Other languages

Norwegian (no)

Inventor

Wolfgang Linz

Ursula Schindler

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-02-04

Filing date

2004-08-31

Publication date

2004-08-31

2004-08-31 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2004-08-31 Publication of NO20043698L publication Critical patent/NO20043698L/en

Links

239000005541 ACE inhibitor Substances 0.000 title 1
206010019280 Heart failures Diseases 0.000 title 1
229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 title 1
IWXNYAIICFKCTM-UHFFFAOYSA-N cariporide Chemical compound CC(C)C1=CC=C(C(=O)N=C(N)N)C=C1S(C)(=O)=O IWXNYAIICFKCTM-UHFFFAOYSA-N 0.000 title 1
229950008393 cariporide Drugs 0.000 title 1
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
230000004064 dysfunction Effects 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical group [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 title 1
210000000056 organ Anatomy 0.000 title 1
230000002265 prevention Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO20043698A 2002-02-04 2004-08-31 Combination preparation of the sodium hydrogen exchange inhibitor cariporide with ACE inhibitors for heart failure prevention and other age-related dysfunctions in organs, age-related diseases and for extended life NO20043698L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10204571		2002-02-04
PCT/EP2003/000587 WO2003066045A1 (en)	2002-02-04	2003-01-22	Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ace inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespan

Publications (1)

Publication Number	Publication Date
NO20043698L true NO20043698L (en)	2004-08-31

Family

ID=27674558

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20043698A NO20043698L (en)	2002-02-04	2004-08-31	Combination preparation of the sodium hydrogen exchange inhibitor cariporide with ACE inhibitors for heart failure prevention and other age-related dysfunctions in organs, age-related diseases and for extended life

Country Status (23)

Country	Link
EP (1)	EP1474134B1 (en)
JP (1)	JP4733348B2 (en)
KR (1)	KR20040083498A (en)
CN (1)	CN1319528C (en)
AR (1)	AR038387A1 (en)
AT (1)	ATE520398T1 (en)
AU (1)	AU2003244430A1 (en)
BR (1)	BR0307443A (en)
CA (1)	CA2474888A1 (en)
CO (1)	CO5601009A2 (en)
HR (1)	HRP20040702A2 (en)
HU (1)	HUP0402593A2 (en)
MA (1)	MA27170A1 (en)
MX (1)	MXPA04007569A (en)
NO (1)	NO20043698L (en)
NZ (1)	NZ534479A (en)
PE (1)	PE20040188A1 (en)
PL (1)	PL370488A1 (en)
RS (1)	RS68204A (en)
RU (1)	RU2004126702A (en)
TW (1)	TW200306850A (en)
WO (1)	WO2003066045A1 (en)
ZA (1)	ZA200406066B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SG184353A1 (en) *	2010-03-31	2012-11-29	Hospital For Sick Children	Use of remote ischemic conditioning to improve outcome after myocardial infarction

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0855392A3 (en) *	1997-01-22	2000-01-05	Hoechst Aktiengesellschaft	Five-membered heterocycles having biphenylsulphonyl substituents, processes for the preparation thereof, their use as medicaments or diagnostic agent and medicaments containing them
DE19734693A1 (en) *	1997-08-11	1998-01-22	Hoechst Marion Roussel De Gmbh	Use of cariporide to treat cardiac and non-cardiac disease
DE19737224A1 (en) *	1997-08-27	1999-03-18	Hoechst Marion Roussel De Gmbh	Pharmaceutical preparation for cardiovascular treatment
US6011059A (en) *	1997-12-24	2000-01-04	Bristol-Myers Squibb Company	Acyl guanidine sodium/proton exchange inhibitors and method
DE19859727A1 (en) *	1998-12-23	2000-06-29	Aventis Pharma Gmbh	The use of inhibitors of the sodium-hydrogen exchanger for the manufacture of a medicament for the prevention of age-related organ dysfunctions, age-related illnesses for the prolongation of life

2003
- 2003-01-22 CN CNB03803185XA patent/CN1319528C/en not_active Expired - Fee Related
- 2003-01-22 RS YUP-682/04A patent/RS68204A/en unknown
- 2003-01-22 MX MXPA04007569A patent/MXPA04007569A/en not_active Application Discontinuation
- 2003-01-22 BR BR0307443-9A patent/BR0307443A/en not_active IP Right Cessation
- 2003-01-22 CA CA002474888A patent/CA2474888A1/en not_active Abandoned
- 2003-01-22 JP JP2003565469A patent/JP4733348B2/en not_active Expired - Fee Related
- 2003-01-22 NZ NZ534479A patent/NZ534479A/en unknown
- 2003-01-22 KR KR10-2004-7012005A patent/KR20040083498A/en not_active Withdrawn
- 2003-01-22 PL PL03370488A patent/PL370488A1/en not_active Application Discontinuation
- 2003-01-22 WO PCT/EP2003/000587 patent/WO2003066045A1/en not_active Ceased
- 2003-01-22 HR HR20040702A patent/HRP20040702A2/en not_active Application Discontinuation
- 2003-01-22 HU HU0402593A patent/HUP0402593A2/en unknown
- 2003-01-22 AU AU2003244430A patent/AU2003244430A1/en not_active Abandoned
- 2003-01-22 RU RU2004126702/15A patent/RU2004126702A/en not_active Application Discontinuation
- 2003-01-22 EP EP03737262A patent/EP1474134B1/en not_active Expired - Lifetime
- 2003-01-22 AT AT03737262T patent/ATE520398T1/en active
- 2003-01-29 TW TW092101906A patent/TW200306850A/en unknown
- 2003-01-31 PE PE2003000115A patent/PE20040188A1/en not_active Application Discontinuation
- 2003-01-31 AR ARP030100296A patent/AR038387A1/en unknown
2004
- 2004-07-27 MA MA27801A patent/MA27170A1/en unknown
- 2004-07-29 ZA ZA200406066A patent/ZA200406066B/en unknown
- 2004-08-03 CO CO04075091A patent/CO5601009A2/en not_active Application Discontinuation
- 2004-08-31 NO NO20043698A patent/NO20043698L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP4733348B2 (en)	2011-07-27
AR038387A1 (en)	2005-01-12
RU2004126702A (en)	2005-04-20
MA27170A1 (en)	2005-01-03
JP2005519072A (en)	2005-06-30
EP1474134A1 (en)	2004-11-10
WO2003066045A1 (en)	2003-08-14
CA2474888A1 (en)	2003-08-14
CN1694697A (en)	2005-11-09
NZ534479A (en)	2006-03-31
MXPA04007569A (en)	2004-11-01
RS68204A (en)	2007-02-05
CN1319528C (en)	2007-06-06
PE20040188A1 (en)	2004-05-17
ZA200406066B (en)	2005-06-08
PL370488A1 (en)	2005-05-30
BR0307443A (en)	2005-01-04
HRP20040702A2 (en)	2005-04-30
TW200306850A (en)	2003-12-01
ATE520398T1 (en)	2011-09-15
KR20040083498A (en)	2004-10-02
EP1474134B1 (en)	2011-08-17
CO5601009A2 (en)	2006-01-31
AU2003244430A1 (en)	2003-09-02
HUP0402593A2 (en)	2005-04-28

Similar Documents

Publication	Publication Date	Title
MXJL06000006A (en)	2006-05-04	Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases.
WO2007109251A3 (en)	2007-12-13	Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
EA201391705A1 (en)	2014-07-30	TRIAZOLPIRIDINE INHIBITORS 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE I
EA200802329A1 (en)	2009-06-30	TRIAZOLE DERIVATIVES II
DK1753748T3 (en)	2009-10-05	Proline derivatives and their use as dipeptidyl peptidase IV inhibitors
DK1956004T3 (en)	2012-08-06	Quinoline derivatives and their use as 5-HT6 ligands
NO20053356L (en)	2005-07-11	Aminindazole derivatives and their use as kinase inhibitors.
EA200870091A1 (en)	2009-12-30	APPLICATION OF BENZO-CONDENSED HETEROCYCLIC SULFAMIDE DERIVATIVES FOR REMOVAL OF PAIN
NO20043580L (en)	2004-09-21	Quinazolinone derivatives and their use as CB agonists
DK1442023T3 (en)	2007-11-05	Crystalline sodium salt of telmisartan and its use as angiotensin antagonist
NO20075662L (en)	2007-11-07	Roflumilast for the treatment of pulmonary hypertension
ECSP055844A (en)	2005-09-20	NEW TRICYCLE COMPOUNDS
NO20065079L (en)	2006-11-03	Materials and methods for the treatment of coagulation disorders
DK1505871T3 (en)	2013-05-13	Conservation of RNA and Morphology in Cells and Tissues
SG156681A1 (en)	2009-11-26	Use of ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
EA200501557A1 (en)	2006-04-28	NEW METHOD OF SYNTHESIS (2S) -INDOLIN-2-CARBONIC ACID AND USE IN PERINDOPRIL SYNTHESIS
NO20070250L (en)	2007-03-14	S-Tenatoprazole sodium monohydrate salt and its use in the form of a proton pump inhibitor
NO20013145L (en)	2001-08-22	Use of inhibitors of the sodium hydrogen exchanger for the preparation of a drug for the prevention of organ dysfunction and diseases related to a particular age and for a prolonged life
DE60301862D1 (en)	2006-02-23	COMBINATION TREATMENT IN ACUTE MYOKARDINFARKT
DE60305053D1 (en)	2006-06-08	Pyrimidine derivatives as selective COX-2 inhibitors
NO20054216L (en)	2005-09-12	Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin II antagonist for stroke prevention
DK1496918T3 (en)	2023-05-15	USE OF SODIUM METHAARSENITE IN THE TREATMENT OF TUMORS
ATE510543T1 (en)	2011-06-15	USE OF CILOBRADINES OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE TREATMENT OR PREVENTION OF HEART FAILURE
BR0312712A (en)	2005-04-26	Modified amino acid for inhibition of platelet aggregation
DE602004002964D1 (en)	2006-12-07	7-AZAINDOL DERIVATIVES AS COX2 INHIBITORS

Legal Events

Date	Code	Title	Description
2008-08-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application